|
Volumn 25, Issue 10, 2010, Pages 686-687
|
The goal blood pressure in type 2 diabetes: Do we have an ACCORD?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIHYPERTENSIVE AGENT;
CREATININE;
POTASSIUM;
TRANDOLAPRIL PLUS VERAPAMIL;
ANTIDIABETIC AGENT;
ACUTE HEART INFARCTION;
ADVERSE OUTCOME;
BLOOD PRESSURE;
BRADYCARDIA;
CARDIOVASCULAR DISEASE;
CARDIOVASCULAR RISK;
COMORBIDITY;
CREATININE BLOOD LEVEL;
DIABETIC HYPERTENSION;
DISEASE ASSOCIATION;
GLOMERULUS FILTRATION RATE;
HAZARD RATIO;
HEART ARRHYTHMIA;
HIGH RISK PATIENT;
HUMAN;
HYPERKALEMIA;
HYPERTENSION;
HYPOKALEMIA;
HYPOTENSION;
MEDICAL SOCIETY;
NON INSULIN DEPENDENT DIABETES MELLITUS;
POTASSIUM BLOOD LEVEL;
PRACTICE GUIDELINE;
RETROSPECTIVE STUDY;
SHORT SURVEY;
SYSTOLIC BLOOD PRESSURE;
TREATMENT OUTCOME;
ARTICLE;
PATHOPHYSIOLOGY;
ANTIHYPERTENSIVE AGENTS;
BLOOD PRESSURE;
DIABETES MELLITUS, TYPE 2;
GUIDELINE ADHERENCE;
HUMANS;
HYPERTENSION;
HYPOGLYCEMIC AGENTS;
PRACTICE GUIDELINES AS TOPIC;
|
EID: 79953001281
PISSN: 08885109
EISSN: None
Source Type: Journal
DOI: 10.4140/TCP.n.2010.686 Document Type: Short Survey |
Times cited : (1)
|
References (8)
|